We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PSSA3:BMFBOVESPAPorto Seguro S.A. Analysis

Data as of 2026-03-17 - not real-time

R$47.34

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Porto Seguro is trading at R$47.34, comfortably below its 20‑day (R$50.77), 50‑day (R$49.85) and 200‑day (R$50.20) moving averages, indicating short‑term weakness. The RSI of 33 suggests the stock is approaching oversold territory, while a bearish MACD and stable volume reinforce a cautious near‑term outlook. Yet the market sentiment is extremely bullish, with the Fear & Greed Index at 79.45 (Extreme Greed) and volatility at a high 27.6% over the past month.
Fundamentally, the company posted R$43.3 bn in revenue growing 29% YoY, and trades at a PE of 9.1 versus an industry average of 16.5, highlighting a clear valuation discount. A dividend yield of 4.95% with a payout ratio just under 50% points to sustainable income, and the DCF model implies a fair value near R$74, offering roughly 15% upside to current levels. Analysts collectively rate the stock as a “buy” with median price targets around R$55.
Risk is moderated by a low beta of 0.29, solid operating cash flow, and decent liquidity (average 10‑day volume ~1.67 m shares). However, moderate leverage (debt‑to‑equity ~4.5) and Brazil‑specific regulatory and currency exposure temper the profile. Overall, the blend of attractive valuation, strong dividend, and growth prospects supports a buy stance for medium to long horizons, while short‑term positioning remains neutral pending a technical bounce.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages signals weakness
  • RSI near oversold levels may trigger a bounce
  • Bearish MACD and high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation discount (PE 9.1 vs industry 16.5)
  • Strong dividend yield of 4.95% with sustainable payout
  • Robust revenue growth of 29% and analyst buy rating

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Diversified insurance and financial services platform
  • Low beta indicating defensive characteristics
  • DCF fair value suggests substantial upside and durable cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth29.10%
Profit Margin7.81%
P/E Ratio9.1
ROE22.82%
ROA6.11%
Debt/Equity4.54
P/B Ratio1.9
Op. Cash FlowR$1.4B
Free Cash FlowR$-219600256
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI33.0
SupportR$0.00
ResistanceR$53.10
MA 20R$50.77
MA 50R$49.85
MA 200R$50.20
MACDBearish
VolumeStable
Fear & Greed Index79.45

Valuation

Fair ValueR$74.00
Target PriceR$54.36
Upside/Downside14.84%
GradeUndervalued
TypeBlend
Dividend Yield4.95%

Risk Assessment

Beta0.29
Volatility27.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.